source
- Pharma groups urge FDA to clarify criteria for approving drugs based on a single pivotal trialPharmaceutical companies and industry associations are asking the U.S. Food and Drug Administration for more detailed guidance on when a single pivotal clinical trial, supported by additional confi…
- Anew Labs, ByteDance’s biotech spinout, raises $290M to build a China AI bio rivalAnew Labs, a biotech spinout from ByteDance, announced it has secured $290 million in funding. The capital came from a mix of Chinese investors such as HSG, IDG Capital and Hillhouse Investment, a…